Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-30 Manke Isaac Director Grant or award +6,311 9,780
2025-06-30 Mathers Edward T Director Grant or award +4,694 7,274
2025-06-23 Saccomano Nicholas A President and CEO Sale −88 $2.38 $210 3,594
2025-06-23 Leverone Jason A. Chief Financial Officer Sale −303 $2.38 $722 12,906
2025-05-28 Phillips Andrew John Director Grant or award · Stock Option (right to buy) +7,650 7,650
2025-05-28 Manke Isaac Director Grant or award · Stock Option (right to buy) +7,650 7,650
2025-05-28 Jansen Valerie Malyvanh Director Grant or award · Stock Option (right to buy) +7,650 7,650
2025-05-28 GREY MICHAEL G Director Grant or award · Stock Option (right to buy) +7,650 7,650
2025-05-28 Carruthers R Michael Director Grant or award · Stock Option (right to buy) +7,650 7,650
2025-05-28 Mathers Edward T Director Grant or award · Stock Option (right to buy) +7,650 7,650
2025-05-15 ACORN BIOVENTURES, L.P. 10% owner Purchase +270,270 $1.85 $500K 1,709,944
2025-05-15 ACORN BIOVENTURES, L.P. 10% owner Purchase +1,129,730 $1.85 $2.1M 1,129,730
2025-05-15 Cormorant Asset Management, LP Former 10% Owner Sale −1,813,439 $1.85 $3.4M 0
2025-05-12 Cormorant Asset Management, LP 10% owner Sale −24,300 $1.99 $48K 1,813,439
2025-04-07 Saccomano Nicholas A President and CEO Sale −516 $2.67 $1K 3,682
2025-04-07 Leverone Jason A. Chief Financial Officer Sale −1,844 $2.67 $5K 13,209
2025-04-04 Saccomano Nicholas A President and CEO Sale −358 $3.33 $1K 4,198
2025-04-04 Leverone Jason A. Chief Financial Officer Sale −1,278 $3.33 $4K 15,053
2025-03-31 Manke Isaac Director Grant or award +3,469 3,469
2025-03-31 Mathers Edward T Director Grant or award +2,580 2,580

Page 4 of 8 · 154 trades